Professor Trevor Jones CBE

Trevor was appointed to the Board in October 2015 as a Non-Executive Director and appointed Independent Non-Executive Chairman in March 2021. Trevor has over 40 years’ distinguished experience in the pharmaceutical and biotechnology industry as well as in academia. He is a member of the Boards of Techimmune LLC and Ascension Healthcare plc and a Visiting Professor at King’s College London; he holds honorary degrees and Gold Medals from seven universities. Previously, Trevor held significant roles in industry including Director of Allergan Inc. from 2005 to 2015 and R&D Director of The Wellcome Foundation from 1987 to 1994, where he was responsible for the development of AZT, Zovirax, Lamictal, Malarone and other medicines. Trevor has also held a number of advisory and regulatory roles including Director General of the Association of the British Pharmaceutical Industry (“ABPI”); board member of the European Federation of Pharmaceutical Industries and Associations (“EFPIA”) and the International Federation of Pharmaceutical Manufacturers & Associations (“IFPMA”); a member of the UK Government regulatory agency The Medicines Commission; a member of the UK Government Pharmaceutical Industry Ministerial Strategy Working Group on Pharmaceuticals; an advisor to the Cabinet Office on the Human Genome Project; a member of the Prime Minister’s Task Force on the Competitiveness of the Pharmaceutical Industry (“PICTF”); and Chair of the Government Advisory Group on Genetics Research.